Tecentriq Injection
Marketer
Roche Products India Pvt Ltd
Salt Composition
Atezolizumab (840mg)
Overview Tecentriq Injection
Atezolizumab, administered intravenously, is a monoclonal antibody indicated for various cancers including non-small cell lung cancer, small cell lung cancer, liver cancer (hepatocellular carcinoma), and melanoma. Intravenous administration is strictly under medical supervision, with dosage and frequency determined by your physician based on your specific condition and potentially adjusted over time. Adhere precisely to your doctor's instructions; incorrect usage or overdose can lead to severe adverse reactions. Therapeutic benefits may take weeks or months to manifest; do not discontinue treatment without your doctor's consent. Common side effects include tiredness, nausea, reduced appetite, constipation, cough, and breathlessness. Serious side effects like chest pain, diarrhea, or dark urine necessitate immediate medical attention. Report any concerning side effects to your doctor; management strategies may be available. Prior to treatment, inform your doctor of any pre-existing heart, liver, or kidney conditions, and all other medications, including anti-infectives, as interactions are possible. This medication is contraindicated during pregnancy and breastfeeding; reliable contraception is crucial for both partners. A patient support program is accessible in India through Tata 1mg; inquire with your physician or call (1800-102-1618) for further information.
Uses of Tecentriq Injection
Therapeutic approaches for small cell lung cancer, non-small cell lung cancer, melanoma, and hepatocellular carcinoma.
Major Benefits of Tecentriq Injection:
Administering this medication will be done by your doctor or nurse; please do not attempt self-medication.
Common Side effects of Tecentriq Injection:
- Fatigue
- Weakness
- Decreased appetite
- Nausea
- Cough
- Breathlessness
- Constipation
How to use Tecentriq Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Tecentriq Injection works:
Atezolizumab, administered via injection, is a monoclonal antibody that inhibits a protein found on T lymphocytes—immune system regulatory white blood cells. This blockade reactivates T-cell cytotoxicity, enhancing the immune response to identify and eliminate malignant cells.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Tecentriq Injection lacks established safety data. Physician consultation is advised.
PregnancyCONSULT YOUR DOCTOR
Using Tecentriq Injection during pregnancy may pose risks. While human data is scarce, animal studies indicate potential harm to a developing fetus. A physician will assess the advantages against possible risks prior to prescribing. Physician consultation is advised.
Breast feedingCONSULT YOUR DOCTOR
The use of Tecentriq Injection while breastfeeding is likely inadvisable. Available human data indicates a potential for the medication to transfer to breast milk, posing a risk to the infant.
DrivingCONSULT YOUR DOCTOR
The effect of Tecentriq Injection on driving ability is unknown. Refrain from driving if you experience symptoms impairing concentration or reaction time.
KidneyCONSULT YOUR DOCTOR
Data on Tecentriq Injection's use in patients with renal impairment is scarce. Physician consultation is recommended.
LiverCONSULT YOUR DOCTOR
Data regarding Tecentriq Injection's use in patients exhibiting hepatic impairment is scarce. Physician consultation is advised.
What if you forget to take Tecentriq Injection :
NA
Facts to Know About Tecentriq Injection
| Label | Value |
|---|---|
| Chemical Category | Short protein chains |
| Developing Habits | No. |
| Type of Treatment | Cancer Drugs |
| Actions | PD-1 Checkpoint Blockade Therapy |
3,018 People bought this recently